Roche Executive To Be Named Gilead Ceo

Gilead Sciences is planning to hire industry veteran Daniel O’Day to take the helm and help the drug company revive sales and recover from a disappointing deal.

Topics:  gilead sciences   daniel o day   
BING NEWS:
  • Roche Vet O’Day Tapped to Shape Gilead’s Future as Hep C Sales Fall
    Daniel O’Day, a veteran executive from Swiss pharma giant Roche, has been tapped for one of the top jobs in biotech. He’s been named the CEO of Gilead Sciences (NASDAQ: GILD), which is searching for a ...
    12/10/2018 - 12:59 am | View Link
  • Roche vet named Gilead CEO — and Genentech boss moves to Switzerland — in shuffle of top Bay Area biotech execs
    Gilead Sciences Inc. landed former Roche executive Daniel O'Day as its new CEO, and Genentech Inc.'s current CEO will take O'Day's role with Genentech's parent company in a game of musical chairs disc...
    12/9/2018 - 11:03 pm | View Link
  • Roche's O’Day swaps big pharma for big biotech
    Gilead has selected Daniel O'Day, the current chief executive of Roche's pharma business ... Gilead’s chairman Jon Martin, who also said he will depart once a new CEO was named, said O’Day is “uniquel...
    12/9/2018 - 10:05 pm | View Link
  • Gilead Sciences snares Roche veteran O'Day as CEO
    (Reuters) - Drugmaker Gilead Sciences Inc on Monday named Roche Holding AG’s Daniel O’Day as its new chief executive, tapping an industry veteran to fill a management vacuum. O’Day ...
    12/9/2018 - 9:13 pm | View Link
  • Gilead Sciences snares Roche veteran O'Day as CEO
    (Reuters) - Drugmaker Gilead Sciences Inc on Monday named Roche Holding AG’s Daniel O’Day as its new chief executive, tapping an industry veteran to fill a management vacuum. O’Day, now head of Roche’ ...
    12/9/2018 - 1:27 pm | View Link
  • More
BING SEARCH:
  • Stocks
    Updated world stock indexes. Get an overview of major world indexes, current values and stock market data.
    01/7/2019 - 5:11 pm | View Website
  • Deanna J. Reichel | Attorney, Minneapolis | Fish
    Deanna J. Reichel is a Principal in the Twin Cities office of Fish & Richardson P.C. She is a member of the firm’s pharmaceutical litigation group and has extensive experience in Hatch-Waxman and other life sciences cases, from the due diligence phase through trial.
    01/7/2019 - 2:41 pm | View Website
  • Press Releases | Adimab
    Lebanon, New Hampshire – January 8, 2018 – Adimab, LLC, the global leader in the discovery and optimization of fully human monoclonal and bispecific antibodies, today announced that in 2017 it entered into agreements with seven new companies.
    01/7/2019 - 7:39 am | View Website
  • Atlas Team
    Nessan is co-founder and was previously chief executive officer of Intellia Therapeutics. He led Intellia from seed investment and incubation at Atlas Venture through its IPO and the advancement of its gene editing platform toward clinical development.
    01/7/2019 - 6:20 am | View Website
  • Stock Exchange News
    Please note that once you make your selection, it will apply to all future visits to NASDAQ.com. If, at any time, you are interested in reverting to our default settings, please select Default ...
    01/6/2019 - 2:57 pm | View Website
  • More
Welcome to Wopular!

Welcome to Wopular

Wopular is an online newspaper rack, giving you a summary view of the top headlines from the top news sites.

Senh Duong (Founder)
Wopular, MWB, RottenTomatoes

Subscribe to Wopular's RSS Fan Wopular on Facebook Follow Wopular on Twitter Follow Wopular on Google Plus

MoviesWithButter : Our Sister Site

More News